Discussion
Left ventricular thrombus with normal systolic functions is a very rare condition. Only 31 cases were reported with male predominance (%58) (1). The predisposing factors are inflammatory conditions, malignancies, blood dyscrasias, hypercoagulable states as lupus anticoagulant and diagnostic work-up for these situations are advised (1). The apex of the left ventricle is the most common site of thrombus in the ischemic and non-ischemic myocardium and although there are no guidelines or recommendation reports for the treatment of left ventricular thrombus in patients with normal systolic functions, anticoagulation therapies with or without surgical removal is recommended for these patients. The anticoagulation algorithms advised for intracardiac thrombus in the reduced left ventricle functions might be used. As the United States guidelines recommend the usage of a vitamin K antagonist with a target level of INR between 2.0-2.5 or dabigatran, rivaroxaban or apixaban for 3 months, European guidelines recommend the treatment up to 6 months (2-6).